Longeveron Inc (LGVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGVN | APUS | NEUP | ||
| Company | Longeveron Inc | Apimeds Pharmaceuticals US Inc | Neuphoria Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 0.9496 | 1.8800 | 4.28 | ||
| High | 0.9496 | 1.8800 | 4.28 | ||
| Low | 0.9496 | 1.7100 | 3.84 | ||
| Latest | 0.9496 | 1.7500 | 3.94 | ||
| Change | +0.0192 | -0.1600 | -0.16 | ||
| % Change | +2.06% | -8.38% | -3.90% | ||
| Volume | 14,098 | 31,600 | 74,400 | ||
| 20-Day Average Volume | 15,996,154 | 109,440 | 69,595 | ||
| Previous Close | 0.9304 | 1.9100 | 4.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.8513 | 1.6000 | 4.48 | ||
| 20-Day Raw Stochastic | 63.70% | 57.83% | 9.09% | ||
| 20-Day Relative Strength | 59.70 | 52.90 | 39.69 | ||
| Weighted Alpha | -25.12 | -30.51 | -23.89 | ||
| Today's Opinion | 56% Buy | 24% Sell | 56% Sell | ||
| Previous Opinion | 40% Buy | 8% Buy | 48% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.28% since 03/24/26 | -10.26% since 03/23/26 | -14.53% since 03/23/26 | ||
| Low | 0.8760 on 03/27/26 | 1.6000 on 03/24/26 | 3.84 on 03/30/26 | ||
| High | 0.9900 on 03/26/26 | 1.9100 on 03/27/26 | 4.61 on 03/24/26 | ||
| 1-Month | |||||
| %Chg | +75.40% since 02/27/26 | +28.68% since 02/27/26 | -5.06% since 02/27/26 | ||
| Low | 0.4750 on 03/06/26 | 1.2500 on 03/02/26 | 3.84 on 03/30/26 | ||
| High | 1.2200 on 03/16/26 | 2.1000 on 03/20/26 | 4.94 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | +78.33% since 12/26/25 | -1.69% since 12/26/25 | +5.91% since 12/26/25 | ||
| Low | 0.4750 on 03/06/26 | 0.9510 on 02/13/26 | 3.64 on 12/29/25 | ||
| High | 1.2200 on 03/16/26 | 3.0000 on 01/23/26 | 4.94 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +18.86% since 09/26/25 | -9.33% since 09/26/25 | -67.99% since 09/26/25 | ||
| Low | 0.4750 on 03/06/26 | 0.9510 on 02/13/26 | 3.64 on 12/29/25 | ||
| High | 1.2200 on 03/16/26 | 4.0310 on 11/17/25 | 21.40 on 10/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 21,649 | 22,008 | 21,240 | ||
| Shares Outstanding, K | 23,268 | 12,576 | 5,391 | ||
| Annual Sales | 1,200,000 | 0 | 15,650,000 | ||
| Annual Net Income | -22,700,000 | -1,390,000 | -370,000 | ||
| Last Quarter Sales | 370,000 | 0 | 0 | ||
| Last Quarter Net Income | -5,440,000 | -1,780,000 | 1,860,000 | ||
| 60-Month Beta | 0.23 | N/A | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 03/17/26 | -0.14 on 11/12/25 | -0.77 on 02/17/26 | ||
| Latest Earnings Date | 05/14/26 | 04/21/26 | 05/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||